Venue

This is a virtual event, accessible over the phone. Access instructions will be provided after registration.

Description

This is a complimentary program sponsored by Manatt, Phelps & Phillips, LLP.

As the crisis of addiction accelerates, experts project that opioids could kill nearly half a million Americans over the next decade. Already, close to 100 people a day die from opioids—bringing immeasurable pain to families and billions of dollars in costs to the U.S. economy. Worst case scenarios predict that the death toll could spike to 250 a day. Even middle of the road forecasts anticipate that by 2027 annual U.S. deaths from opioids alone may surpass the worst year of AIDS deaths at the peak of that epidemic1.

How did the crisis begin? Where are we now? And what can we do going forward? In a new webinar, Manatt provides the answers, examining the opioid crisis from the diverse viewpoints of its affected stakeholders, including victims and their families, first responders and law enforcement agencies, pharmaceutical manufacturers, states and cities, and public and private payers.

The program will take a multifaceted approach, exploring the opioid epidemic, its current status and potential solutions from the legal, clinical and policy perspectives. It will reveal the origins of the crisis…provide insight into how government, law enforcement and private industry have responded to date…and look ahead to what can be done to change laws, regulations and treatment protocols to ameliorate the crisis in the future.

1STAT Forecast, June 27, 2017

Educational Objectives:
• Understand the genesis and drivers of the opioid crisis from multiple vantage points.
• Explore short- and long-term strategies that cities, states and the federal government are using to address the crisis through litigation, enforcement and regulation.
• Discover the actions being taken to address the crisis in both the public and private sectors.
• Analyze opioid-related civil and criminal cases brought by cities and counties, state attorneys general and the Department of Justice.
• Learn how False Claims Act theories used in other pharma cases may be applied in opioid cases moving forward.
• Examine the innovative solutions emerging across the full range of stakeholders, including pharmaceutical companies, government payer programs and private insurers.
• Determine the next steps for cities and states, in terms of policies, education, community engagement, treatment options and more.
• Find out what the future holds for law enforcement, from the increasing use of data analytics to new theories of liability.

Who would benefit most from attending this program?
Administrator, Analyst/Specialist, Attorney/Counsel, Board Member, Consultant, CEO/President, General Counsel, Managing Partner, Of Counsel, Paralegal, Partner, Practice Group Leader

Presenters

Joel S. Ario

Managing Director

Manatt Health

With 30 years of experience shaping and implementing public health policy at the state and federal levels, Joel Ario provides strategic consulting and analysis on healthcare policies and institutions, with an emphasis on public and private exchange-based marketplaces. He represents state governments, health plans, hospitals, foundations and other entities.

Joel's experience includes two decades of leading health insurance reform efforts for state and federal governments. As director of the Office of Health Insurance Exchanges at the U.S. Department of Health & Human Services, he worked closely with states and other stakeholders to develop the regulatory framework for exchanges, including the rights and responsibilities of states and the federal government in expanding coverage.

On the state level, Joel served as Pennsylvania Insurance Commissioner and Oregon Insurance Commissioner. He also served on the executive committee of the National Association of Insurance Commissioners and was an NAIC officer.

The author of several articles on healthcare reform, Joel serves as an advisor to the Robert Wood Johnson Foundation in support of its work with states and has written extensively on 1332 state innovation waivers. Joel is based in Manatt's Albany office.

Rick defends companies against allegations of white collar crime, healthcare fraud and environmental violations, and advises on cross border security and trade issues, as well as cybersecurity, employment and defense procurement matters. He also helps clients manage crises that result from litigation and government enforcement efforts, particularly when investigations involve multiple agencies and jurisdictions.During his tenure as United States Attorney for the Northern District of New York, Rick headed several key initiatives and prosecutions. He strengthened his office s Civil Division, emphasizing affirmative civil enforcement to combat healthcare and procurement fraud, and he worked closely with the FBI and U.S. Department of Homeland Security on cybercrime, including trade secret and customer data theft. Rick now advises companies that are under scrutiny by the government or are victims of cyberattacks by criminal organizations or state actors and provides counsel on preemptive measures.Rick has substantial knowledge of and good working relationships with U.S. and Canadian border security agencies, enabling him to assist U.S. and Canadian businesses that have pressing border related concerns. Rick also has experience with Native American tribal affairs and gaming matters.Frequently interviewed by the legal press, Rick is also regularly invited to address both public and private organizations, including county, state, federal and national bar associations.

Jocelyn A. Guyer

Managing Director

Manatt Health

Jocelyn Guyer provides policy expertise, strategic advice and technical support to states, foundations and a range of clients on the successful implementation of the Affordable Care Act (ACA), delivery system reform, Medicaid and the Children's Health Insurance Program (CHIP).

With decades of health policy work, Jocelyn possesses a nuanced perspective on delivery system reform, coverage and eligibility issues, and IT systems. She has served as an advisor to the National Academy for State Health Policy and the American Academy of Pediatrics, among others.

Throughout her career Jocelyn has been a speaker at national gatherings of state officials, provider organizations, advocacy groups and foundations. She has presented to members of Congress, as well as state and local officials, on the future of children's coverage, transforming Medicaid and implementing federal health reform.

Jacqueline C. Wolff is co-chair of the Corporate Investigations and White Collar Defense group of Manatt, Phelps & Phillips, LLP in the firm’s New York office. She has spent over 30 years defending companies and individuals accused of white collar crimes and False Claims Act violations. A former Chief of the Environmental Crimes Unit and Assistant United States Attorney for the Frauds Division in the District of New Jersey, Jacqueline focuses her practice on violations of the Foreign Corrupt Practices Act (FCPA), fraud-based crimes including healthcare, securities and tax fraud, and immigration crimes. She has successfully defended multiple clients in False Claims Act cases resulting in declinations from the government, resolutions as overpayment cases or, where the government decided not to intervene, outright dismissals of the qui tam. Jacqueline has also represented corporate clients ranging from Fortune 100 companies to small venture capital firms in FCPA investigations and criminal immigration matters. She has successfully represented corporate officers in tax and securities fraud matters.

While in the United States Attorney's Office, Jacqueline received numerous awards, including those from the Immigration and Naturalization Service, the U.S. Nuclear Regulatory Commission, the U.S. Environmental Protection Agency and the Attorney General of the United States.

Jacqueline received her J.D. from Fordham University School of Law and her B.A. from the University of Pennsylvania.

Sandy W. Robinson

Managing Directory

Manatt Health

Sandy Robinson uses her knowledge of reimbursement and health policy analyses, technology solutions, patient support program design and communications across multiple care settings to advise life sciences clients on holistic market access strategies that support patient care and access to medications within the community, particularly for those with chronic conditions.

Adept at identifying innovative solutions, Sandy has expertise in helping clients navigate the complexities of payer, provider, pharmacy and patient segments across the healthcare industry. She frequently speaks on strategic market access topics at industry conferences.

Prior to joining Manatt, Sandy was executive vice president of Nexus Informatics, where she led the launch of the company’s innovative patient support data technology platform in the marketplace. Before that, as senior vice president of Avalere Health, she advised clients on strategic product commercialization and market access issues, with a specialty in design and redesign of comprehensive patient support programs.

Earlier, Sandy, as executive director, Market Access Solutions and Center for Pricing and Reimbursement at United BioSource Corp., led teams dedicated to improving access to biopharmaceuticals, devices, and diagnostics from prelaunch through post-approval. At the beginning of her career, Sandy managed a unit devoted to processing all hospital-based patient claims.

As an independent consultant, Sandy conducted healthcare research for pharmaceutical companies, health alliances and other healthcare research and consulting firms seeking strategic market analyses for products in development.